|
Market Closed -
Nasdaq
04:00:00 2026-10-19 pm EDT
|
5-day change | 1st Jan Change | ||
| 8.070 USD | +3.59% |
|
-5.61% | +3.46% |
| Oct. 19 | Wedbush Cuts Price Target on BioCryst Pharmaceuticals to $18 From $20, Keeps Outperform Rating | MT |
| Oct. 05 | Biocryst Pharmaceuticals, Inc. Announces Formation of Scientific Advisory Board | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BCRX | Delayed | |
CBOE
| BCRX | Real-time | |
|
Mexican S.E.
| BCRX * | End-of-day quote | |
|
Tradegate
| BO1 | Real-time | |
|
Boerse Muenchen
| BO1 | Real-time | |
|
Deutsche Boerse AG
| BO1 | Delayed | |
|
Börse Stuttgart
| BO1 | Delayed | |
|
Berne S.E.
| BO1 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 8.29 | 9.55 | 10.45 |
| Spread/Res. | -2.65% | -15.50% | -22.78% |
| Spread/Supp. | +5.35% | +16.96% | +26.49% |
| Support | 7.66 | 6.9 | 6.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BCRX Stock
- Charts BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
